Similar articles for PMID: 11579459

Year	Number of Results
1996	1
1997	4
1998	5
1999	8
2000	15
2001	6
2002	12
2003	7
2004	8
2005	11
2006	6
2007	11
2008	13
2009	4
2010	8
2011	11
2012	6
2013	5
2014	9
2015	5
2016	8
2017	9
2018	6
2019	13
2020	14
2021	17
2022	9
2023	3
2024	0

1

Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect.

Auroy S, Avril MF, Chompret A, Pham D, Goldstein AM, Bianchi-Scarrà G, Frebourg T, Joly P, Spatz A, Rubino C, Demenais F, Bressac-de Paillerets B; French Hereditary Melanoma Study Group. Auroy S, et al. Genes Chromosomes Cancer. 2001 Nov;32(3):195-202. doi: 10.1002/gcc.1183. Genes Chromosomes Cancer. 2001. PMID: 11579459

2

Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients.

Mantelli M, Pastorino L, Ghiorzo P, Barile M, Bruno W, Gargiulo S, Sormani MP, Gliori S, Vecchio S, Ciotti P, Sertoli MR, Queirolo P, Goldstein AM, Bianchi-Scarrà G; Italian Melanoma Intergroup. Mantelli M, et al. Melanoma Res. 2004 Dec;14(6):443-8. doi: 10.1097/00008390-200412000-00002. Melanoma Res. 2004. PMID: 15577313

3

CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.

Della Torre G, Pasini B, Frigerio S, Donghi R, Rovini D, Delia D, Peters G, Huot TJ, Bianchi-Scarra G, Lantieri F, Rodolfo M, Parmiani G, Pierotti MA. Della Torre G, et al. Br J Cancer. 2001 Sep 14;85(6):836-44. doi: 10.1054/bjoc.2001.1991. Br J Cancer. 2001. PMID: 11556834 Free PMC article.

4

CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.

Hashemi J, Platz A, Ueno T, Stierner U, Ringborg U, Hansson J. Hashemi J, et al. Cancer Res. 2000 Dec 15;60(24):6864-7. Cancer Res. 2000. PMID: 11156381

5

Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma.

Tsao H, Zhang X, Kwitkiwski K, Finkelstein DM, Sober AJ, Haluska FG. Tsao H, et al. Arch Dermatol. 2000 Sep;136(9):1118-22. doi: 10.1001/archderm.136.9.1118. Arch Dermatol. 2000. PMID: 10987867

6

Search for germline alterations in CDKN2A/ARF and CDK4 of 42 Jewish melanoma families with or without neural system tumours.

Marian C, Scope A, Laud K, Friedman E, Pavlotsky F, Yakobson E, Bressac-de Paillerets B, Azizi E. Marian C, et al. Br J Cancer. 2005 Jun 20;92(12):2278-85. doi: 10.1038/sj.bjc.6602629. Br J Cancer. 2005. PMID: 15928671 Free PMC article.

7

Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanoma.

Nikolaou V, Kang X, Stratigos A, Gogas H, Latorre MC, Gabree M, Plaka M, Njauw CN, Kypreou K, Mirmigi I, Stefanaki I, Tsao H. Nikolaou V, et al. Br J Dermatol. 2011 Dec;165(6):1219-22. doi: 10.1111/j.1365-2133.2011.10551.x. Epub 2011 Nov 2. Br J Dermatol. 2011. PMID: 21801156 Free PMC article.

8

CDKN2A (P16(INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: effect of family history and multiple primary melanomas.

Holland EA, Schmid H, Kefford RF, Mann GJ. Holland EA, et al. Genes Chromosomes Cancer. 1999 Aug;25(4):339-48. Genes Chromosomes Cancer. 1999. PMID: 10398427

9

CDKN2A mutations in multiple primary melanomas.

Monzon J, Liu L, Brill H, Goldstein AM, Tucker MA, From L, McLaughlin J, Hogg D, Lassam NJ. Monzon J, et al. N Engl J Med. 1998 Mar 26;338(13):879-87. doi: 10.1056/NEJM199803263381305. N Engl J Med. 1998. PMID: 9516223 Free article.

10

Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.

Goldstein AM, Struewing JP, Chidambaram A, Fraser MC, Tucker MA. Goldstein AM, et al. J Natl Cancer Inst. 2000 Jun 21;92(12):1006-10. doi: 10.1093/jnci/92.12.1006. J Natl Cancer Inst. 2000. PMID: 10861313

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

218 results

Results by year